LASV inhibitor 3.3 is a Lassa fever virus ( LASV ) inhibitor. LASV inhibitor 3.3 binds with LASV glycoprotein (GP) and promotes virus membrane fusion and infection. LASV inhibitor 3.3 can be used for LASV infection research.In VitroLASV inhibitor 3.3 (1 nM-100 μM; 1 h) inhibits transduction by murine leukemia virus (MLV) pseudotyped with the indicated viral glycoproteins with an IC 50 value of 1.8 μM. LASV inhibitor 3.3 (1 and 10 μM; 1 h) inhibits LAMP1 binding to LASV GP in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: 293T LAMP1 KO cells expressing LASV GP-His and 293T pX459 cells Concentration: 1 and 10 μM Incubation Time: 1 hour Result: Inhibited the LASV GP binds to LAMP1.Form:Solid. Specification: 0.99 Molecular Formula: C30H37N3O2 Molecular Weight: 471.63 PubChem CID: 5082945 Isomeric SMILES: C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CNC(=O)C45CC6CC(C4)CC(C6)C5
- UPC:
- 12352005
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- L650254-5mg
- CAS:
- 554438-52-7
- Product Size:
- 5mg
